Antibiotic Choice for Children Hospitalized With Pneumonia and Adherence to National Guidelines

Derek J Williams1, Kathryn M Edwards2, Wesley H Self3

  • 1Divisions of Hospital Medicine and Department of Pediatrics, Vanderbilt University School of Medicine, Vanderbilt Vaccine Research Program, Nashville, Tennessee; derek.williams@vanderbilt.edu.

Pediatrics
|June 24, 2015
PubMed

Insights

National guidelines for childhood community-acquired pneumonia (CAP) led to decreased use of broad-spectrum antibiotics and increased use of narrow-spectrum ones like ampicillin. Hospital-based efforts enhanced guideline implementation and antibiotic prescribing changes.

Area of Science:

  • Pediatric Infectious Diseases
  • Antimicrobial Stewardship
  • Public Health Guidelines

Background:

  • National guidelines in 2011 recommended narrow-spectrum antibiotics for childhood community-acquired pneumonia (CAP).
  • The study evaluated the impact of these guidelines on antibiotic prescribing practices in three children's hospitals.

Purpose of the Study:

  • To assess the effect of national CAP management guidelines on antibiotic selection in hospitalized children.
  • To determine if hospital-level implementation efforts influenced adherence to the guidelines.

Main Methods:

  • A cohort of 2121 children with CAP was studied from January 2010 to June 2012.
  • Antibiotic prescribing patterns (third-generation cephalosporins vs. penicillin/ampicillin) were analyzed pre- and post-guideline implementation.
  • Segmented linear regression compared observed prescribing with projected use.

Main Results:

  • Third-generation cephalosporin use decreased by 12.4% and penicillin/ampicillin use increased by 11.3% within 9 months post-guidelines.
  • Significant changes in antibiotic prescribing were most evident in hospitals actively disseminating the guidelines.
  • Initial use of third-generation cephalosporins was 52.8% versus 2.7% for penicillin/ampicillin pre-guidelines.

Conclusions:

  • National guidelines for CAP successfully shifted antibiotic prescribing towards narrower-spectrum agents.
  • Proactive dissemination of guidelines within hospitals correlated with more substantial changes in prescribing patterns.
  • Targeted, hospital-based implementation strategies are crucial for effective guideline adoption.
Abstract

Related Concept Videos

Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
1.1K
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
4.0K
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
1.2K
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease...
51
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
383
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
701